Endometrial Adenosquamous Carcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Endometrial Adenosquamous Carcinoma

subtype

Identifier: CI-CAN-00007635
Entity page: /cancer/endometrial-adenosquamous-carcinoma ↗
Edges: 26

Neighbours: 14 drugs10 trials
Drawn: 24 of 24 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Endometrial Adenosquamous Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived14 of 14
→ investigated in trials for	Paclitaxelsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Endometrial Adenosquamous Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants

Endometrial Adenosquamous Carcinoma studied in …STUDIED_INderived10 of 12show all (up to 200)
→ studied in	NCT00977574Phase 2 · active not recruiting Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active)	—	—	Endometrial Adenosquamous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01935934Phase 2 · completed Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active)	—	—	Endometrial Adenosquamous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active)	—	—	Endometrial Adenosquamous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01307631Phase 2 · completed Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active)	—	—	Endometrial Adenosquamous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01132820Phase 2 · completed Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active)	—	—	Endometrial Adenosquamous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01011933Phase 2 · completed Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active)	—	—	Endometrial Adenosquamous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01005329Phase 2 · completed Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active)	—	—	Endometrial Adenosquamous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01210222Phase 2 · completed Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active)	—	—	Endometrial Adenosquamous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00820898Phase 2 · completed Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active)	—	—	Endometrial Adenosquamous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00575952Phase 1 · completed Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active)	—	—	Endometrial Adenosquamous Carcinoma	1	Observed	clinicaltrials	graph →